Editor’s note: The Amyloidosis News Today team provided in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22. Go here to read the…
hATTR-PN
Note: This article was updated to include information from a Hopkins study published on May 5, 2021, of responses after a second vaccine dose was given…
HATTR-PN
ColumnsA Little Understanding Can Go a Long Way for Rare Disease Sufferers
When you live with a rare illness, it can affect every facet of life. I am a carer to my husband, Aubrey, who has…
Precision BioScience’s gene-editing therapy for transthyretin amyloidosis (ATTR), a group of disorders that also encompasses familial amyloid polyneuropathy (FAP), shows therapeutic potential in…
Editor’s note: The Amyloidosis News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22. Go here to read more…
HATTR-PN
ColumnsAs a Caregiver, I’m Learning to Chase Happiness
One activity I really enjoy doing is going for coffee dates with my girlfriends. This allows me to take a break from my normal routine…
Editor’s note: The Amyloidosis News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22. Go here to read the…
HATTR-PN
News#AANAM – Onpattro Reduced Nervous System Damage in Trial
Editor’s note: The Amyloidosis News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22. Go here to read more…
More than half of the people with rare diseases and their caregivers, asked in a survey, were undecided or less than willing to be vaccinated…
Editor’s note: The Amyloidosis News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22. Go here to read the…
Recent Posts
- Mental flexibility is key to coping with my role as a caregiver
- Starting Attruby early cuts heart-related risks by half in ATTR-CM
- Amvuttra effective in East Asian patients with hATTR-PN: Trial data
- The long journey to an amyloidosis diagnosis can be full of setbacks
- Physically demanding jobs linked to higher risk of wild-type ATTR-CM